Evidence map›Paper›PMID 29916053›Full record

ArticlePharmaceutical research2018

Crystallization from Supersaturated Solutions: Role of Lecithin and Composite Simulated Intestinal Fluid.

Anura S Indulkar, Yi Gao, Shweta A Raina, Geoff G Z Zhang, Lynne S Taylor

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anura S IndulkarDepartment of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, Indiana, 47907, USA.
Yi GaoScience & Technology (S&T), Operations, AbbVie Inc., 1401 Sheridan Road, North Chicago, Illinois, 60064, USA.
Shweta A RainaScience & Technology (S&T), Operations, AbbVie Inc., 1401 Sheridan Road, North Chicago, Illinois, 60064, USA.
Geoff G Z ZhangDrug Product Development, Research and Development, AbbVie Inc., 1 N Waukegan Road, North Chicago, Illinois, 60064, USA. Geoff.GZ.Zhang@abbvie.com.
Lynne S TaylorDepartment of Industrial and Physical Pharmacy, College of Pharmacy, Purdue University, 575 Stadium Mall Drive, West Lafayette, Indiana, 47907, USA. lstaylor@purdue.edu.ORCID http://orcid.org/0000-0002-4568-6021
AbbVie (United States) · USPurdue University West Lafayette · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe overall purpose of this study was to understand the impact of different biorelevant media types on solubility and crystallization from supersaturated solutions of model compounds (atazanavir, ritonavir, tacrolimus and cilnidipine). The first aim was to understand the influence of the lecithin content in FaSSIF. As the human intestinal fluids (HIFs) contain a variety of bile salts in addition to sodium taurocholate (STC), the second aim was to understand the role of these bile salts (in the presence of lecithin) on solubility and crystallization from supersaturated solutions,

methodsTo study the impact of lecithin, media with 3 mM STC concentration but varying lecithin concentration were prepared. To test the impact of different bile salts, a new biorelevant medium (Composite-SIF) with a composition simulating that found in the fasted HIF was prepared. The crystalline and amorphous solubility was determined in these media. Diffusive flux measurements were performed to determine the true supersaturation ratio at the amorphous solubility of the compounds in various media. Nucleation induction times from supersaturated solutions were measured at an initial concentration equal to the amorphous solubility (equivalent supersaturation) of the compound in the given medium.

resultsIt was observed that, with an increase in lecithin content at constant STC concentration (3 mM), the amorphous solubility of atazanavir increased and crystallization was accelerated. However, the crystalline solubility remained fairly constant. Solubility values were higher in FaSSIF compared to Composite-SIF. Longer nucleation induction times were observed for atazanavir, ritonavir and tacrolimus in Composite-SIF compared to FaSSIF at equivalent supersaturation ratios.

conclusionsThis study shows that variations in the composition of SIF can lead to differences in the solubility and crystallization tendency of drug molecules, both of which are critical when evaluating supersaturating systems.

Indexed as

AlgorithmsAtazanavir SulfateCalcium Channel BlockersCrystallizationDihydropyridinesHIV Protease InhibitorsHumansImmunosuppressive AgentsIntestinal SecretionsLecithinsPharmaceutical PreparationsRitonavirSolubilitySolutionsTacrolimusAtazanavir SulfateCalcium Channel BlockerscilnidipineDihydropyridinesHIV Protease InhibitorsImmunosuppressive AgentsLecithinsPharmaceutical PreparationsRitonavirSolutionsTacrolimusbiorelevant mediacrystallizationnucleationsimulated intestinal fluidssupersaturation

Identifiers

PMID29916053
OpenAlexW2808873450

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.